Tratamiento con tianeptina de trastornos depresivos en el anciano

Actas Espanolas de Psiquiatria

Volumn 25, Issue 2, 1997, Pages 79-83

  Saiz Ruiz, J ^a   Montes, J M ^a   Alvarez E ^b   Cervera, S ^c   Giner, J ^d   Guerrero, J ^d   Dourdil, F ^d   Seva, A ^d  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b Hospital Sta Cruz y San Pablo ^*  (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Depression; Elderly; Tianeptine

Indexed keywords

THIAZEPINE DERIVATIVE; TIANEPTINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; ARTICLE; CLINICAL TRIAL; DEPRESSION; FEMALE; HUMAN; MALE; PSYCHOLOGICAL ASPECT;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; THIAZEPINES;

EID: 3042943153     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Blazer DG. Depression in the elderly. New England Journal of Medicine 1989;320:164-6.
2. Gurland BJ. The impact of depression on quality of life of the elderly. Clin Ger Med 1992;8:377-86.
3. Salzman C. Practical considerations in the pharmacologic treatment of depression and anxiety in the elderly. J Clin Psychiatry 1990;51:40-3.
4. Kato G, Weitsch AF. Neurochemical profite of tianeptine, a new antidepressant drug. Clinical Neuropharmacology 1988;11(suppl. 2):43-50.
5. Labrid C, Mocaér E, Kamoun A. Neurochemical and pharmacological properties of tianeptine, a novel antidepressant. British Journal of Psychiatry 1992; 160 (suppl. 15):56-60.
6. Mocaër E, Rettori MC, Kamoun A. Pharmacological antidepressive effects and tianeptine-induced 5-HT uptake increase. Clinical Neuropharmacology 1988; 11(suppl. 2):S32-42.
7. Invernizzi G, Aguglia E, Bertolino A, et al. The efficacy and safety of tianeptine in the treatment of depressive disorder: resultats of controlled double-blind multicentre study vs. amitriptyline. Neuropsychobiology 1994;30:85-93.
8. Guelfi DJ. Efficacy of tianeptine in comparative trials versus reference antidepressants. An overview. Bristish Journal of Psychiatry 1992;160(suppl. 15):72-5.
9. Wilde MI, Benfield P. Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression. Drugs 1995;49:411-39.
10. Saiz-Ruiz J, Álvarez E, Cervera S, Dourdil F, Giner J, Guerrero J, López-Ibor JJ, Seva A. Treatment of depression in elderly patients by tianeptine. Presented at XIXth Collegium Internationale Neuro-Psychopharmacologicum Congress, Washington, DC June 27 July 1, 1994.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (third edition). American Psychiatric Association. Washington DC 1980.
12. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979;134:382-389.
13. Demotes-Mainard F, Galley P, Manciet G, et al. Pharmacokinetics of the antidepressant tianeptine at steady state in the elderly. Journal of Clinic Pharmacology 1991;31:174-8.
14. Guy W. ECDEU Assesment Manual for Psychopharmacology. US Dept of Health, Education and Welfare publication. Washington DC 1976:76-338.
15. Hamilton M. The assesment of anxiety states by rating. Br J Psychol 1959;32:50-55.
16. Zung WK. A self-rating depression scale. Arch Gen Psychiatry 1965;12:63-70.
17. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State Examination: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-98.
18. Guelfi JD, Pull CB, Guelfi C, et al. La CHESS, utilisation dans la pathologie anxieuse et dépressive. Structure factorielle. Annales Médico-psychologiques 1983;141:257-78.